Cancer Clinical Trials Results
Collection of Blood and Tissue from Patients with Upper Aerodigestive Malignancies for Research Purposes (The UAM Tissue Resource)
||Main Campus|| || ||Esophageal, Head & Neck, Lung, Mesothelioma, Thyroid
A Phase II Trial of modified FOLFOX-6 Induction Chemotherapy followed by Esophagectomy and post-operative response based chemoradiotherapy in patients with locoregionally advanced adenocarcinoma of the esophagus, gastro-esophageal junction, and gastric cardia.
||Main Campus, North Coast Cancer, Wooster|| || ||Esophageal, Head & Neck
A Four Part, Phase 1, Multi-center, Open-label Study of DKN-01 in
Combination with Weekly Paclitaxel
||Main Campus|| ||Phase 1||Esophageal
A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination with MEDI4736 and MEDI0680 Monotherapy in Subjects with Select Advanced Malignancies
||Main Campus||Advanced/Metastatic||Phase 1, Phase 2||Bladder, Esophageal, GI (Gastrointestinal), Ovarian, Renal
A Phase III Randomized Open-label Study of Single Agent Pembrolizumab vs Physicians’; Choice of Single Agent Docetaxel, Paclitaxel, or Irinotecan in Subjects with Advanced/Metastatic Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus that have Progressed after First-Line Standard Therapy (KEYNOTE-181)
||Main Campus|| ||Phase 3||Esophageal
Cancer Answers & Appointments
Speak with a cancer nurse specialist for appointment assistance and for answers to your questions about cancer locally at 216.444.7923 or toll-free 1.866.223.8100.
Monday through Friday from 8 a.m. – 4:30 p.m. (ET).
Resources for medical professionals
- Outpatient appointment referrals: 216.444.7923 or 866.223.8100
- Inpatient hospital transfers: 800.553.5056
- Referring Physician Concierge: 216.444.6196 or 216.312.4910.
Search available cancer clinical trials by disease, hospital, phase or number.